Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Elena Koundourakis
Ms Koundourakis is head of the Orexin Franchise Development and Portfolio Strategy at Takeda.
Articles
The Role of Orexin Receptor 2 Agonists in Sleep and Narcolepsy Type 1
February 15th 2024Elena Koundourakis, the head of the Orexin Franchise Development and Portfolio Strategy at Takeda, shares her thoughts on the recent positive topline results from a phase 2 trial evaluating TAK-861, an oral orexin receptor 2 agonist, in patients with narcolepsy type 1.
Latest Updated Articles
Published: August 3rd 2015 | Updated: November 23rd 2024
Mini Quiz: DSM-5 Basics
Published: March 19th 2021 | Updated: November 23rd 2024
Mini Quiz: Treatment for Pedophilia?
Published: January 21st 2016 | Updated: November 23rd 2024
Mini Quiz: Methods of Suicide
Published: March 23rd 2021 | Updated: November 23rd 2024
Poor DSM-5—So Misunderstood!
Published: January 23rd 2017 | Updated: November 23rd 2024
Mini Quiz: Characterizing Sexual Deviation
Published: June 6th 2018 | Updated: November 23rd 2024
Mini Quiz: Psychogenic Non-Epileptic Seizures
